Article: NASONEX(R) (Mometasone Furoate Monohydrate) Effective For Nasal Polyps With Once-Daily Dose.

MUNICH, Germany, June 29 /PRNewswire/ --

- Intranasal Corticosteroid Reduces Polyp Grade and Nasal Congestion, With Convenient Dosing

Schering-Plough Corporation (NYSE: SGP) today announced results of a study that found once-daily use of NASONEX(R) (mometasone furoate monohydrate) Nasal Spray, 50 mcg- is effective and safe for the treatment of nasal polyps and nasal congestion related to this condition. The research was presented today at the World Allergy Congress in Munich, Germany.

Nasal polyps are grape-like growths in the nasal cavity that can reduce airflow in the nasal passages, leading to congestion. If unresolved, surgery may be ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!